Clinical Trial Update: Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of pegylated interferon alfa-2a with or without emtricitabine and/or tenofovir disoproxil fumarate for chronic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Drugs mentioned

• Emtricitabine (Emtricitabine)
• Pegylated interferon alfa-2a (Peginterferon alfa-2a)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: University Hospital, Bonn | Conditions: Chronic Hepatitis B, HIV Infections | Phase 3 | Status: TERMINATED